FMR LLC 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-09 08:35 am Sale | 2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 612,427 6.062% | -164,860 (-21.21%) | Filing |
| 2023-02-09 08:23 am Sale | 2023-02-09 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 777,287 7.793% | -310,098 (-28.52%) | Filing |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | Adverum Biotechnologies, Inc. ADVM | FMR LLC | 1,087,385 11.011% | 930,157 (+591.60%) | Filing |